Cerebral vascular disease.
Gorelick
Philip B
PB
Department of Neurology and Rehabilitation Center for Stroke Research Chicago, Illinois, USA.
Ruland
Sean
S
D000208:Acute Disease; D002545:Brain Ischemia / Q000150:complications*; D002543:Cerebral Hemorrhage / Q000150:complications; D048909:Diabetes Complications / Q000150:complications; D055317:Evidence-Based Practice; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D008019:Life Style; D008297:Male; D010348:Patient Care Team / Q000458:organization & administration; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods; D011322:Primary Prevention / Q000379:methods; D012008:Recurrence; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D020521:Stroke / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D014481:United States / Q000453:epidemiology
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors